Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Valuation
- About
Meihua International Medical Technologies Co Ltd (MHUA)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/05/2025: MHUA (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -60.75% | Avg. Invested days 20 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/05/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 14.36M USD | Price to earnings Ratio 1.13 | 1Y Target Price - |
Price to earnings Ratio 1.13 | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.85 | 52 Weeks Range 0.25 - 1.47 | Updated Date 06/29/2025 |
52 Weeks Range 0.25 - 1.47 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.4 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 11.19% | Operating Margin (TTM) 16.33% |
Management Effectiveness
Return on Assets (TTM) 5% | Return on Equity (TTM) 7.09% |
Valuation
Trailing PE 1.13 | Forward PE - | Enterprise Value 6349300 | Price to Sales(TTM) 0.15 |
Enterprise Value 6349300 | Price to Sales(TTM) 0.15 | ||
Enterprise Value to Revenue 0.07 | Enterprise Value to EBITDA 0.4 | Shares Outstanding 31904500 | Shares Floating 15734833 |
Shares Outstanding 31904500 | Shares Floating 15734833 | ||
Percent Insiders 49.95 | Percent Institutions 1.06 |
Upturn AI SWOT
Meihua International Medical Technologies Co Ltd
Company Overview
History and Background
Meihua International Medical Technologies Co Ltd. was founded to develop, manufacture, and sell medical devices in China. While specific founding year details are scarce in publicly available resources, the company has evolved to focus on disposable medical products used in various procedures.
Core Business Areas
- Disposable Medical Devices: Focuses on the manufacturing and distribution of a range of disposable medical devices used in hospitals and other healthcare settings, including various types of tubing, surgical instruments, and other consumables.
Leadership and Structure
Information on the specific leadership team and detailed organizational structure is not readily available in publicly accessible sources.
Top Products and Market Share
Key Offerings
- Infusion Sets: Infusion sets, used for intravenous drug delivery. Market share data for this specific product line is not publicly available. Competitors include major medical device manufacturers like Becton Dickinson (BDX) and ICU Medical (ICUI).
- Various Tubes: Various medical tubes and disposable medical devices are sold to medical facilities. Market share data for this specific product line is not publicly available. Competitors include major medical device manufacturers like Becton Dickinson (BDX) and ICU Medical (ICUI).
Market Dynamics
Industry Overview
The medical device industry is experiencing growth driven by an aging population, increasing healthcare expenditure, and technological advancements. The demand for disposable medical devices is particularly high due to their role in infection control and convenience.
Positioning
Meihua International Medical Technologies Co Ltd. is positioned as a manufacturer and supplier of disposable medical devices. Their competitive advantage would be cost-effectiveness and meeting specific needs of the Chinese market.
Total Addressable Market (TAM)
The global medical device market is projected to reach trillions of dollars. While Meihua International's specific TAM within the global medical device market and position are not precisely quantified, the company focuses on China and specific disposable medical devices.
Upturn SWOT Analysis
Strengths
- Manufacturing capabilities in China
- Focus on disposable medical devices
- Potential for cost-effective production
Weaknesses
- Limited brand recognition
- Dependence on a specific geographical market
- Potential vulnerability to regulatory changes in China
- Lack of diversified product portfolio
Opportunities
- Expanding product offerings
- Entering new geographical markets
- Strategic alliances with other companies
- Increasing demand for disposable medical devices
Threats
- Intense competition from established players
- Changes in government regulations
- Fluctuations in raw material prices
- Economic downturns
Competitors and Market Share
Key Competitors
- BDX
- ICUI
Competitive Landscape
Meihua International Medical Technologies Co Ltd faces stiff competition from established medical device manufacturers with greater resources and brand recognition. Their advantages lie in potentially lower production costs and focus on the Chinese market.
Growth Trajectory and Initiatives
Historical Growth: Historical growth trends can be analyzed using the company's financial reports and stock performance data.
Future Projections: Analyst estimates for future growth can be obtained from financial news sources and research reports.
Recent Initiatives: Recent strategic initiatives can be identified through press releases and company announcements.
Summary
Meihua International Medical Technologies Co Ltd focuses on disposable medical devices in China, presenting opportunities for growth. It's exposed to the threats of regulations, competition, raw material cost and lack of diversified product portfolio. With solid fundamentals, the company shows growth potential. However, it needs to strategically navigate the risks to ensure long-term sustainability.
Similar Stocks
Sources and Disclaimers
Data Sources:
- SEC filings
- Company website
- Financial news sources
- Market research reports
Disclaimers:
The information provided is for informational purposes only and does not constitute investment advice. Market share data is estimated based on available public information and may not be precise.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Meihua International Medical Technologies Co Ltd
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2022-02-16 | CEO & Director Mr. Wang Xin | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 619 | Website https://www.meihuamed.com |
Full time employees 619 | Website https://www.meihuamed.com | ||
Meihua International Medical Technologies Co., Ltd. engages in the research and development, manufacture, and sale of medical devices in the People's Republic of China. The company offers Class I disposable medical devices, including disposable medical X-ray films, medical dry films, dry laser imagers, gauze bandages, examination gloves, pharmaceutical packaging materials and containers, low-density polyethylene bottles for eye drops, and high-density polyethylene bottles for tablets; Class II products, such as disposable full anesthesia kits, medical brush, woman's examination kits, urethral catheterization kits, gynecological examination kits, endotracheal intubation, medical masks, anal bags, and suction connecting tube, etc.; and Class III disposable medical devices, such as disposable infusion pumps, anesthesia puncture kits, electronic pumps, etc. It also offers disposable plastic baby bottles, NB/PSN rubber covers and 8.2mL folded spoons for tools and containers, etc.; Class II 6866 medical polymer materials and products, including transfusion equipment and pipelines, endotracheal intubation for respiratory anesthesia or ventilation; and medical x-ray films and multi-functional self-extracting X-ray film machines. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People's Republic of China.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.